Endoplasmic reticulum stress mediates sulforaphane-induced apoptosis of HepG2 human hepatocellular carcinoma cells

Zou,Xiang; Qu,Zhongyuan; Fang,Yueni; Shi,Xin; Ji,Yubin

doi:10.3892/mmr.2016.6016

Endoplasmic reticulum stress mediates sulforaphane-induced apoptosis of HepG2 human hepatocellular carcinoma cells

Authors:
- Xiang Zou
- Zhongyuan Qu
- Yueni Fang
- Xin Shi
- Yubin Ji
View Affiliations

Affiliations: Engineering Research Center of Natural Antineoplastic Drugs, Ministry of Education, Harbin, Heilongjiang 150076, P.R. China, College of Pharmacy, Harbin University of Commerce, Harbin, Heilongjiang 150076, P.R. China, Post Doctoral Research Center of Materia Medica, Harbin University of Commerce, Harbin, Heilongjiang 150076, P.R. China
Published online on: December 9, 2016 https://doi.org/10.3892/mmr.2016.6016
Pages: 331-338

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sulforaphane (SFN) is a naturally occurring chemopreventive agent, which effectively inhibits proliferation of HepG2 human hepatocellular carcinoma cells via mitochondria‑mediated apoptosis. Endoplasmic reticulum stress is considered the most important cause of cell apoptosis; therefore, the present study aimed to determine whether the endoplasmic reticulum pathway was involved in SFN-induced apoptosis of HepG2 cells. An MTT assay was used to detect the inhibitory effects of SFN on HepG2 cells. Fluorescence microscopy was used to observe the morphological changes in apoptotic cells, and western blot analysis was conducted to detect the expression of binding immunoglobulin protein (Bip)/glucose-regulated protein 78 (GRP78), X‑box binding protein‑1 (XBP‑1) and BH3 interacting domain death agonist (Bid). Furthermore, flow cytometry was used to determine the apoptotic rate of HepG2 cells, and the protein expression of C/EBP homologous protein (CHOP)/growth arrest‑ and DNA damage‑inducible gene 153 (GADD153) and caspase-12 in HepG2 cells. The results indicated that SFN significantly inhibited the proliferation of HepG2 cells; the half maximal inhibitory concentration values were 32.03±0.96, 20.90±1.96 and 13.87±0.44 µmol/l, following treatment with SFN for 24, 48 and 72 h, respectively. Following 48 h of SFN treatment (10, 20 and 40 µmol/l), the apoptotic rates of HepG2 cells were 31.8, 61.3 and 77.1%, respectively. Furthermore, after 48 h of exposure to SFN, the cells presented typical morphological alterations of apoptosis, as detected under fluorescence microscopy. Treatment with SFN for 48 h also significantly upregulated the protein expression levels of Bip/GRP78, XBP‑1, caspase‑12, CHOP/GADD153 and Bid in HepG2 cells. In conclusion, endoplasmic reticulum stress may be considered the most important mechanism underlying SFN-induced apoptosis in HepG2 cells.

View Figures

View References

1	Wei KR, Yu X, Zheng RS, Peng XB, Zhang SW, Ji MF, Liang ZH, Ou ZX and Chen WQ: Incidence and mortality of liver cancer in China, 2010. Chin J Cancer. 33:388–394. 2014.PubMed/NCBI
2	Bernard WS and Chrstopher PW: World cancer report 2014. IARC; Lyon: 2014
3	Fan YG, Wang JB, Jiang Y, Li P, Xiao HJ, Chen WQ, Qiao YL and Boffetta P: Attributable causes of lung cancer mortality and incidence in China. Asian Pac J Cancer Prev. 14:7251–7256. 2013. View Article : Google Scholar : PubMed/NCBI
4	Ji YB, Qu ZY and Zou X: Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway. Exp Toxicol Pathol. 63:69–78. 2011. View Article : Google Scholar : PubMed/NCBI
5	Traka MH, Melchini A and Mithen RF: Sulforaphane and prostate cancer interception. Drug Discov Today. 19:1488–1492. 2014. View Article : Google Scholar : PubMed/NCBI
6	Abdull Razis AF and Noor NM: Sulforaphane is superior to glucoraphanin in modulating carcinogen-metabolising enzymes in Hep G2 cells. Asian Pac J Cancer Prev. 14:4235–4238. 2013. View Article : Google Scholar : PubMed/NCBI
7	Sawai Y, Murata H, Horii M, Koto K, Matsui T, Horie N, Tsuji Y, Ashihara E, Maekawa T, Kubo T and Fushiki S: Effectiveness of sulforaphane as a radiosensitizer for murine osteosarcoma cells. Oncol Rep. 29:941–945. 2013.PubMed/NCBI
8	Li SH, Fu J, Watkins DN, Srivastava RK and Shankar S: Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway. Mol Cell Biochem. 373:217–227. 2013. View Article : Google Scholar : PubMed/NCBI
9	Sharma C, Sadrieh L, Priyani A, Ahmed M, Hassan AH and Hussain A: Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol. 35:272–278. 2011. View Article : Google Scholar : PubMed/NCBI
10	Chang CC, Hung CM, Yang YR, Lee MJ and Hsu YC: Sulforaphane induced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/CDC2 in human ovarian cancer cells. J Ovarian Res. 6:412013. View Article : Google Scholar : PubMed/NCBI
11	Choi S, Lew KL, Xiao H, Herman-Antosiewicz A, Xiao D, Brown CK and Singh SV: D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis. 28:151–162. 2007. View Article : Google Scholar : PubMed/NCBI
12	Jo GH, Kim GY, Kim WJ, Park KY and Choi YH: Sulforaphane induces apoptosis in T24 human urinary bladder cancer cells through a reactive oxygen species-mediated mitochondrial pathway: The involvement of endoplasmic reticulum stress and the Nrf2 signaling pathway. Int J Oncol. 45:1497–1506. 2014.PubMed/NCBI
13	Suppipat K, Park CS, Shen Y, Zhu X and Lacorazza HD: Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells. PLoS One. 7:e512512012. View Article : Google Scholar : PubMed/NCBI
14	Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, Kamarh R, Brown KD, Zhang L and Baskaran R: Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J Biol Chem. 279:25813–25822. 2004. View Article : Google Scholar : PubMed/NCBI
15	Bryant CS, Kumar S, Chamala S, Shah J, Pal J, Seward S, Qazi AM, Morris R, Semaan A, Shammas MA, et al: Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells. Mol Cancer. 9:472010. View Article : Google Scholar : PubMed/NCBI
16	Zou X, Qu ZY and Ji YB: Study on JNK pathway in human hapetocelluar carcinoma HepG-2 cells apoptosis induced by sulforaphane. Journal of Harbin University of Commerce Natural Sciences Edition. 27:532–535. 2011.
17	Zou X, Qu ZY, Gao P, Sun SN and Ji Yb: Effects of sulforaphane on G_2/M phase arrest in HepG-2 cells and the expression of Cdk1 and CyclinB1. Acta Chinese Medicine and Pharmacology. 38:8–10. 2010.
18	Yeh CT and Yen GC: Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis. 26:2138–2148. 2005. View Article : Google Scholar : PubMed/NCBI
19	Jeon YK, Yoo DR, Jang YH, Jang SY and Nam MJ: Sulforaphane induces apoptosis in human hepatic cancer cells through inhibition of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by hypoxia inducible factor-1-dependent pathway. Biochim Biophys Acta. 1814:1340–1348. 2011. View Article : Google Scholar : PubMed/NCBI
20	Zou X, Qu ZY, Gao P and Ji YB: Effects of sulforaphane on gene transcription and protein expression of Bcl-2 and Bax in HepG-2 Cell. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai. 24:76–80. 2010.
21	Herr I, Lozanovski V, Houben P, Schemmer P and Büchler MW: Sulforaphane and related mustard oils in focus of cancer prevention and therapy. Wien Med Wochenschr. 163:80–88. 2013. View Article : Google Scholar : PubMed/NCBI
22	Juge N, Mithen RF and Traka M: Molecular basis for chemoprevention by sulforaphane: A comprehensive review. Cell Mol Life Sci. 64:1105–1127. 2007. View Article : Google Scholar : PubMed/NCBI
23	Xiao D, Powolny AA, Antosiewicz J, Hahm ER, Bommareddy A, Zeng Y, Desai D, Amin S, Herman-Antosiewicz A and Singh SV: Cellular responses to cancer chemopreventive agent D,L-sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species. Pharm Res. 26:1729–1738. 2009. View Article : Google Scholar : PubMed/NCBI
24	Wang L, Tian Z, Yang Q, Li H, Guan H, Shi B, Hou P and Ji M: Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway. Oncotarget. 6:25917–25931. 2015. View Article : Google Scholar : PubMed/NCBI
25	Mondal A, Biswas R, Rhee YH, Kim J and Ahn JC: Sulforaphene promotes Bax/Bcl2, MAPK-dependent human gastric cancer AGS cells apoptosis and inhibits migration via EGFR, p-ERK1/2 down-regulation. Gen Physiol Biophys. 35:25–34. 2016.PubMed/NCBI
26	Park SY, Kim GY, Bae SJ, Yoo YH and Choi YH: Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol Rep. 18:181–187. 2007.PubMed/NCBI
27	Zou X, Qu ZY, Bai J and Ji YB: Effect of sulforaphane on protein expression of ERK and pathway in human hapetocelluar carcinoma HepG-2 cells. Journal of Harbin University of Commerce (Natural Sciences Edition). 27257–258. (266)2011.
28	Franceschelli S, Moltedo O, Amodio G, Tajana G and Remondelli P: In the Huh7 hepatoma cells diclofenac and indomethacin activate differently the unfolded protein response and induce ER stress apoptosis. Open Biochem J. 5:45–51. 2011. View Article : Google Scholar : PubMed/NCBI
29	Zhou Y, Lee J, Reno CM, Sun C, Chung J, Lee J, Fisher SJ, White MF, Biddinger SB and Ozcan U: Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction. Nat Med. 17:356–365. 2011. View Article : Google Scholar : PubMed/NCBI
30	Chen X, Fu XS, Li CP and Zhao HX: ER stress and ER stress-induced apoptosis are activated in gastric SMCs in diabetic rats. World J Gastroenterol. 20:8260–8267. 2014. View Article : Google Scholar : PubMed/NCBI
31	Harshberger CA, Harper AJ, Carro GW, Spath WE, Hui WC, Lawton JM and Brockstein BE: Outcomes of computerized physician order entry in an electronic health record after implementation in an outpatient oncology setting. J Oncol Pract. 7:233–237. 2011. View Article : Google Scholar : PubMed/NCBI
32	Uchibayashi R, Tsuruma K, Inokuchi Y, Shimazawa M and Hara H: Involvement of Bid and caspase-2 in endoplasmic reticulum stress- and oxidative stress-induced retinal ganglion cell death. J Neurosci Res. 89:1783–1794. 2011. View Article : Google Scholar : PubMed/NCBI